Long-term safety and efficacy of imatinib in pulmonary arterial hypertension

被引：0

作者：

Hoeper, Marius ^{[1
]}

Barst, Robyn ^{[2
]}

Galie, Nazzareno ^{[3
]}

Hassoun, Paul ^{[4
]}

Morrell, Nicholas ^{[5
,6
]}

Peacock, Andrew ^{[7
]}

Simonneau, Gerald ^{[8
]}

Tapson, Victor ^{[9
]}

Torres, Fernando ^{[10
]}

Lawrence, David ^{[11
]}

Quinn, Deborah ^{[12
]}

Ghofrani, Hossein Ardeschir ^{[13
]}

机构：

[1] Med Hsch, Resp Med, Hannover, Germany

[2] Columbia Univ, Resp Med, New York, NY USA

[3] Azienda Osped Univ Bologna, Resp Med, Bologna, Italy

[4] Johns Hopkins Univ, Resp Med, Baltimore, MD USA

[5] Addenbrookes Hosp, Resp Med, Cambridge, England

[6] Papworth Hosp, Resp Med, Cambridge, England

[7] Golden Jubilee Natl Hosp, Resp Med, Glasgow, Lanark, Scotland

[8] Univ Paris Sud XI, Resp Med, Orsay, France

[9] Duke Univ, Med Ctr, Resp Med, Durham, NC USA

[10] UT Southwestern Med Ctr, Resp Med, Dallas, TX USA

[11] Novartis Horsham Res Ctr, Resp Med, Horsham, W Sussex, England

[12] Novartis Pharmaceut, Resp Med, Cambridge, MA USA

[13] Univ Hosp Giessen & Marburg GmbH, Resp Med, Giessen, Germany

来源：

EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷

关键词：

Pulmonary hypertension; Treatments;

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

3488

引用

页数：2

共 50 条

[21] Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: A systematic review
Wang, Rong-chun
Jiang, Fa-ming
Zheng, Qiao-ling
Li, Chun-tao
Peng, Xia-ying
He, Chen-yun
Luo, Jian
Liang, Zong-an
RESPIRATORY MEDICINE, 2014, 108 (03) : 531 - 537
[22] Population pharmacokinetics of imatinib in patients with pulmonary arterial hypertension
Bouillon, Thomas
Renard, Didier
Zhou, Ping
Flesch, Gerard
Quinn, Debbie
EUROPEAN RESPIRATORY JOURNAL, 2013, 42
[23] Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial Hypertension
Cai, Zongye
Klein, Theo
Geenen, Laurie W.
Tu, Ly
Tian, Siyu
van den Bosch, Annemien E.
de Rijke, Yolanda B.
Reiss, Irwin K. M.
Boersma, Eric
Duncker, Dirk J.
Boomars, Karin A.
Guignabert, Christophe
Merkus, Daphne
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
[24] Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension
Yeager, Michael E.
Colvin, Kelley L.
Everett, Allen D.
Stenmark, Kurt R.
Ivy, D. Dunbar
PROTEOMICS CLINICAL APPLICATIONS, 2012, 6 (5-6) : 257 - 267
[25] Von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension
Kawut, SM
Horn, EM
Berekashvili, KK
Widlitz, AC
Rosenzweig, EB
Barst, RJ
CHEST, 2005, 128 (04) : 2355 - 2362
[26] The long-term response to treatment with calcium channel blockers in a patient with idiopathic pulmonary arterial hypertension
Solik, P.
Lesny, P.
Luknar, M.
Varga, I
Goncalvesova, E.
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2013, 114 (05): : 283 - 286
[27] Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin.: Long-term results
López-Guarch, CJ
Subias, PE
de Meneses, ST
Jiménez, JFD
Pérez, DS
Martín, MTV
Sánchez, MAG
de la Calzada, CS
REVISTA ESPANOLA DE CARDIOLOGIA, 2004, 57 (10): : 946 - 951
[28] Long-term treatment of pulmonary hypertension with aerosolized iloprost
Machherndl, S
Kneussl, M
Baumgartner, H
Schneider, B
Petkov, V
Schenk, P
Lang, IM
EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (01) : 8 - 13
[29] Long-term outcomes of treatment with bosentan in pulmonary hypertension
Roman, Antonio
Gispert, Pilar
Monforte, Victor
Bravo, Carlos
Domingo, Enric
Morell, Ferran
ARCHIVOS DE BRONCONEUMOLOGIA, 2006, 42 (12): : 616 - 620
[30] Long term combination treatment for severe idiopathic pulmonary arterial hypertension
Affuso, Flora
Cirillo, Plinio
Ruvolo, Antonio
Carlomagno, Guido
Fazio, Serafino
WORLD JOURNAL OF CARDIOLOGY, 2010, 2 (03): : 68 - 70

← 1 2 3 4 5 →